(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are ZoomInfo, Ecolab, and Owens.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | ZoomInfo (ZI) | 18.25 | 13.92% | 2024-02-13 15:18:00 |
| 2 | Ecolab (ECL) | 220.89 | 8.82% | 2024-02-13 15:54:41 |
| 3 | Owens (OI) | 16.80 | 8.25% | 2024-02-13 01:42:06 |
| 4 | Merrimack Pharmaceuticals (MACK) | 15.08 | 7.79% | 2024-02-13 15:13:33 |
| 5 | Nu Skin Enterprises (NUS) | 18.72 | 6.36% | 2024-02-12 23:13:05 |
| 6 | Oil (ODC) | 69.72 | 6.02% | 2024-02-13 01:13:05 |
| 7 | Navios Maritime Partners LP (NMM) | 29.85 | 5.22% | 2024-02-12 21:08:05 |
| 8 | North European Oil Royality Trust (NRT) | 5.09 | 4.3% | 2024-02-12 23:07:06 |
| 9 | Permian Basin Royalty Trust (PBT) | 13.90 | 4.28% | 2024-02-13 03:49:06 |
| 10 | NextEra Energy Partners, LP (NEP) | 29.24 | 4.09% | 2024-02-12 19:08:05 |
The three biggest losers today are WESCO, FibroGen, and Shopify.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | WESCO (WCC) | 134.93 | -29.92% | 2024-02-13 15:00:03 |
| 2 | FibroGen (FGEN) | 2.26 | -16.91% | 2024-02-13 15:12:14 |
| 3 | Shopify (SHOP) | 77.64 | -12.88% | 2024-02-13 15:50:03 |
| 4 | Roku (ROKU) | 87.95 | -10.77% | 2024-02-13 15:17:15 |
| 5 | Full House Resorts (FLL) | 4.95 | -10.47% | 2024-02-13 15:12:25 |
| 6 | Aware, Inc. (AWRE) | 1.75 | -10.26% | 2024-02-13 15:10:56 |
| 7 | Arcturus Therapeutics (ARCT) | 37.37 | -10.21% | 2024-02-13 15:15:47 |
| 8 | Pacific Biosciences of California (PACB) | 6.05 | -9.84% | 2024-02-13 15:14:13 |
| 9 | Plug Power (PLUG) | 4.13 | -9.74% | 2024-02-13 14:14:10 |
| 10 | Canopy Growth (CGC) | 3.44 | -9.48% | 2024-02-13 15:23:21 |
Winners today
1. ZoomInfo (ZI) – 13.92%
ZoomInfo Technologies Inc., through its subsidiaries, provides go-to-market intelligence and engagement platform for sales and marketing teams in the United States and internationally. The company's cloud-based platform provides information on organizations and professionals to help users identify target customers and decision makers, obtain continually updated predictive lead and company scoring, monitor buying signals and other attributes of target companies, craft messages, engage through automated sales tools, and track progress through the deal cycle. It serves enterprises, mid-market companies, and down to small businesses that operate in various industry verticals, including software, business services, manufacturing, telecommunications, financial services, retail, media and internet, transportation, education, hospitality, and real estate. ZoomInfo Technologies Inc. was founded in 2007 and is headquartered in Vancouver, Washington.
NASDAQ ended the session with ZoomInfo jumping 13.92% to $18.25 on Tuesday while NASDAQ slid 1.8% to $15,655.60.
Earnings Per Share
As for profitability, ZoomInfo has a trailing twelve months EPS of $0.27.
PE Ratio
ZoomInfo has a trailing twelve months price to earnings ratio of 67.59. Meaning, the purchaser of the share is investing $67.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.12%.
Sales Growth
ZoomInfo’s sales growth is 3% for the present quarter and 2.8% for the next.
Previous days news about ZoomInfo
- Zoominfo (zi) Q4 earnings and revenues top estimates. According to Zacks on Monday, 12 February, "While ZoomInfo has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
More news about ZoomInfo.
2. Ecolab (ECL) – 8.82%
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
NYSE ended the session with Ecolab rising 8.82% to $220.89 on Tuesday, following the last session’s upward trend. NYSE slid 1.7% to $17,037.32, after five sequential sessions in a row of gains, on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, Ecolab has a trailing twelve months EPS of $4.3.
PE Ratio
Ecolab has a trailing twelve months price to earnings ratio of 51.37. Meaning, the purchaser of the share is investing $51.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.79%.
Moving Average
Ecolab’s value is way higher than its 50-day moving average of $197.01 and way higher than its 200-day moving average of $181.89.
Yearly Top and Bottom Value
Ecolab’s stock is valued at $220.89 at 16:32 EST, above its 52-week high of $203.62.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Dec 18, 2023, the estimated forward annual dividend rate is 2.28 and the estimated forward annual dividend yield is 1.12%.
More news about Ecolab.
3. Owens (OI) – 8.25%
O-I Glass, Inc., through its subsidiaries, engages in the manufacture and sale of glass containers to food and beverage manufacturers primarily in the Americas, Europe, and internationally. The company produces glass containers for alcoholic beverages, including beer, flavored malt beverages, spirits, and wine. It is also involved in the production of glass packaging for various food items, soft drinks, tea, juices, and pharmaceuticals. In addition, the company offers glass containers in a range of sizes, shapes, and colors. It sells its products directly to customers under annual or multi-year supply agreements, as well as through distributors. The company was founded in 1903 and is headquartered in Perrysburg, Ohio.
NYSE ended the session with Owens jumping 8.25% to $16.80 on Tuesday, following the last session’s upward trend. NYSE dropped 1.7% to $17,037.32, after five consecutive sessions in a row of gains, on what was an all-around bearish trend trading session today.
Earnings Per Share
As for profitability, Owens has a trailing twelve months EPS of $-0.67.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.11%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Owens’s EBITDA is 23.9.
Moving Average
Owens’s worth is higher than its 50-day moving average of $15.56 and below its 200-day moving average of $18.22.
Yearly Top and Bottom Value
Owens’s stock is valued at $16.80 at 16:32 EST, way under its 52-week high of $23.57 and way above its 52-week low of $13.56.
Sales Growth
Owens’s sales growth is negative 3.7% for the current quarter and 2.4% for the next.
Previous days news about Owens
- Owens corning (oc) to buy masonite, eyes strategic reviews for GR. According to Zacks on Monday, 12 February, "Shares of Owens Corning lost 7.1% during the trading session but gained 1.8% in the after-hour trading session on Feb 9, 2024.", "Shares of Owens Corning have surged 45.6% in the past year, outperforming the Zacks Building Products – Miscellaneous industry’s 41% growth. "
More news about Owens.
4. Merrimack Pharmaceuticals (MACK) – 7.79%
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
NASDAQ ended the session with Merrimack Pharmaceuticals rising 7.79% to $15.08 on Tuesday while NASDAQ slid 1.8% to $15,655.60.
Earnings Per Share
As for profitability, Merrimack Pharmaceuticals has a trailing twelve months EPS of $-0.1.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.96%.
More news about Merrimack Pharmaceuticals.
5. Nu Skin Enterprises (NUS) – 6.36%
Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
NYSE ended the session with Nu Skin Enterprises rising 6.36% to $18.72 on Tuesday while NYSE fell 1.7% to $17,037.32.
Earnings Per Share
As for profitability, Nu Skin Enterprises has a trailing twelve months EPS of $1.23.
PE Ratio
Nu Skin Enterprises has a trailing twelve months price to earnings ratio of 15.22. Meaning, the purchaser of the share is investing $15.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.03%.
More news about Nu Skin Enterprises.
6. Oil (ODC) – 6.02%
Oil-Dri Corporation of America, together with its subsidiaries, develops, manufactures, and markets sorbent products in the United States and internationally. It operates in two segments, Retail and Wholesale Products Group, and Business to Business Products Group. The company provides agricultural and horticultural products, including mineral-based absorbent products that serve as carriers for biological and chemical active ingredients, drying agents, and growing media under the Agsorb, Verge, and Flo-Fre brand names. It also offers animal health and nutrition products for the livestock industry under the Amlan, Calibrin, Varium, Neoprime, Sorbiam, Ambio P, Ambio S, MD-09, and Pel-Unite and Pel-Unite Plus brand names; and bleaching adsorbent products for bleaching, purification, and filtration applications under the Pure-Flo, Perform, Select, Metal-X, Metal-Z, and Ultra-Clear brand names. In addition, the company provides cat litter products, such as scoopable and non-clumping litters under the Cat's Pride and Jonny Cat brand names; industrial and automotive sorbent products from clay, polypropylene, and recycled materials that absorb oil, acid, paint, ink, water, and other liquids under the Oil-Dri brand name; and sports products for use on baseball, softball, football, cricket, and soccer fields under the Pro's Choice brand name. Its customers include mass merchandisers, wholesale clubs, drugstore chains, pet specialty retail outlets, dollar stores, retail grocery stores, distributors of industrial cleanup and automotive products, environmental service companies, and sports field product and sports turf material users; processors and refiners of edible oils, petroleum-based oils, and biodiesel fuel; manufacturers of animal feed and agricultural chemicals; distributors of animal health and nutrition products; and marketers of consumer products. Oil-Dri Corporation of America was founded in 1941 and is headquartered in Chicago, Illinois.
NYSE ended the session with Oil rising 6.02% to $69.72 on Tuesday while NYSE slid 1.7% to $17,037.32.
Oil flat with plenty moving parts on middle eastThe jump in Oil comes with additional US sanctions shelving Russian-friendly Oil tankers which are floating around with empty cargo. , Crude Oil (WTI) trades at $76.88 per barrel, and Brent Oil trades at $81.96 per barrel at the time of writing.
Earnings Per Share
As for profitability, Oil has a trailing twelve months EPS of $5.15.
PE Ratio
Oil has a trailing twelve months price to earnings ratio of 13.54. Meaning, the purchaser of the share is investing $13.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.59%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Oil’s EBITDA is 24.44.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Feb 22, 2024, the estimated forward annual dividend rate is 1.16 and the estimated forward annual dividend yield is 1.76%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.1%, now sitting on 425.92M for the twelve trailing months.
Moving Average
Oil’s worth is above its 50-day moving average of $66.02 and way higher than its 200-day moving average of $59.06.
Previous days news about Oil
- According to FXStreet on Monday, 12 February, "On Friday, Baker Hughes released its US Oil Rig Count data, indicating no change in the active rig count, which remained steady at 499. ", "Additionally, the OPEC Monthly Oil Market Report (MOMR) is scheduled for publication on Tuesday. "
- Marathon oil (mro) ascends while market falls: some facts to note. According to Zacks on Monday, 12 February, "The investment community will be paying close attention to the earnings performance of Marathon Oil in its upcoming release. ", "The Oil and Gas – Integrated – United States industry is part of the Oils-Energy sector. "
- WTI crude oil weekly forecast: prices edged higher going into last weekend – 11 February 2024. According to DailyForex on Sunday, 11 February, "Having seen a steady amount of buying which propelled WTI Crude Oil above the 77.000 briefly, there was one last selling motion which again tested the 76.000 ratio. ", "If so, this may be a signal WTI Crude Oil traders have found a higher equilibrium speculatively and believe higher prices may remain attractive."
More news about Oil.
7. Navios Maritime Partners LP (NMM) – 5.22%
Navios Maritime Partners L.P. owns and operates dry cargo vessels in Asia, Europe, North America, and Australia. The company offers seaborne transportation services for a range of liquid and dry cargo commodities, including crude oil, refined petroleum, chemicals, iron ore, coal, grain, fertilizer, and containers, as well as charters its vessels under short, medium, and longer-term charters. Olympos Maritime Ltd. serves as the general partner of Navios Maritime Partners L.P. The company was founded in 2007 and is based in Monaco.
NYSE ended the session with Navios Maritime Partners LP jumping 5.22% to $29.85 on Tuesday, following the last session’s upward trend. NYSE slid 1.7% to $17,037.32, after five successive sessions in a row of gains, on what was an all-around down trend exchanging session today.
Earnings Per Share
As for profitability, Navios Maritime Partners LP has a trailing twelve months EPS of $13.62.
PE Ratio
Navios Maritime Partners LP has a trailing twelve months price to earnings ratio of 2.19. Meaning, the purchaser of the share is investing $2.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.24%.
More news about Navios Maritime Partners LP.
8. North European Oil Royality Trust (NRT) – 4.3%
North European Oil Royalty Trust, a grantor trust, holds overriding royalty rights covering gas and oil production in various concessions or leases in the Federal Republic of Germany. The company has rights under contracts with German exploration and development subsidiaries of ExxonMobil Corp. and the Royal Dutch/Shell Group of Companies. It holds royalties for the sale of gas well gas, oil well gas, crude oil, condensate, and sulfur. North European Oil Royalty Trust is based in Keene, New Hampshire.
NYSE ended the session with North European Oil Royality Trust jumping 4.3% to $5.09 on Tuesday, following the last session’s upward trend. NYSE fell 1.7% to $17,037.32, after five successive sessions in a row of gains, on what was an all-around bearish trend exchanging session today.
Earnings Per Share
As for profitability, North European Oil Royality Trust has a trailing twelve months EPS of $2.4.
PE Ratio
North European Oil Royality Trust has a trailing twelve months price to earnings ratio of 2.12. Meaning, the purchaser of the share is investing $2.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3565.7%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
North European Oil Royality Trust’s EBITDA is -576.78.
Volume
Today’s last reported volume for North European Oil Royality Trust is 83269 which is 15.32% below its average volume of 98339.
Yearly Top and Bottom Value
North European Oil Royality Trust’s stock is valued at $5.09 at 16:32 EST, way under its 52-week high of $16.36 and above its 52-week low of $4.77.
Revenue Growth
Year-on-year quarterly revenue growth declined by 99.8%, now sitting on 22.14M for the twelve trailing months.
More news about North European Oil Royality Trust.
9. Permian Basin Royalty Trust (PBT) – 4.28%
Permian Basin Royalty Trust, an express trust, holds overriding royalty interests in various oil and gas properties in the United States. The company owns a 75% net overriding royalty interest in the Waddell Ranch properties comprising Dune, Sand Hills (Judkins), Sand Hills (McKnight), Sand Hills (Tubb), University-Waddell (Devonian), and Waddell fields located in Crane County, Texas. It also holds a 95% net overriding royalty in the Texas Royalty properties, which consist of various producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole, and others located in 33 counties in Texas. Its Texas Royalty properties comprise approximately 125 separate royalty interests containing approximately 51,000 net producing acres. The company was founded in 1980 and is based in Dallas, Texas.
NYSE ended the session with Permian Basin Royalty Trust jumping 4.28% to $13.90 on Tuesday, after two consecutive sessions in a row of gains. NYSE dropped 1.7% to $17,037.32, after five sequential sessions in a row of gains, on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, Permian Basin Royalty Trust has a trailing twelve months EPS of $0.62.
PE Ratio
Permian Basin Royalty Trust has a trailing twelve months price to earnings ratio of 22.42. Meaning, the purchaser of the share is investing $22.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12333%.
Yearly Top and Bottom Value
Permian Basin Royalty Trust’s stock is valued at $13.90 at 16:32 EST, way under its 52-week high of $27.77 and higher than its 52-week low of $13.11.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Permian Basin Royalty Trust’s EBITDA is 308.21.
Volume
Today’s last reported volume for Permian Basin Royalty Trust is 140660 which is 5.85% below its average volume of 149400.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Dec 28, 2023, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 3.98%.
More news about Permian Basin Royalty Trust.
10. NextEra Energy Partners, LP (NEP) – 4.09%
NextEra Energy Partners, LP acquires, owns, and manages contracted clean energy projects in the United States. It owns a portfolio of contracted renewable generation assets consisting of wind, solar, and battery storage projects, as well as contracted natural gas pipeline assets. NextEra Energy Partners, LP was incorporated in 2014 and is headquartered in Juno Beach, Florida.
NYSE ended the session with NextEra Energy Partners, LP jumping 4.09% to $29.24 on Tuesday, after two successive sessions in a row of gains. NYSE slid 1.7% to $17,037.32, after five sequential sessions in a row of gains, on what was an all-around bearish trend trading session today.
Earnings Per Share
As for profitability, NextEra Energy Partners, LP has a trailing twelve months EPS of $0.34.
PE Ratio
NextEra Energy Partners, LP has a trailing twelve months price to earnings ratio of 86. Meaning, the purchaser of the share is investing $86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.65%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Feb 5, 2024, the estimated forward annual dividend rate is 3.44 and the estimated forward annual dividend yield is 12.26%.
More news about NextEra Energy Partners, LP.
Losers Today
1. WESCO (WCC) – -29.92%
WESCO International, Inc. provides business-to-business distribution, logistics services, and supply chain solutions in the United States, Canada, and internationally. It operates through three segments: Electrical & Electronic Solutions (EES), Communications & Security Solutions (CSS), and Utility and Broadband Solutions (UBS). The EES segment supplies products and supply chain solutions, including electrical equipment and supplies, automation and connected devices, security, lighting, wire and cable, and safety, as well as maintenance, repair, and operating (MRO) products. This segment also offers contractor solutions, direct and indirect manufacturing supply chain optimization programs, lighting and renewables advisory services, and digital and automation solutions. The CSS segment operates in the network infrastructure and security markets. This segment sells products directly to end-users or through various channels, including data communications contractors, security, network, professional audio/visual, and systems integrators. It also provides safety and energy management solutions. The UBS segment offers products and services to investor-owned utilities; public power companies; and service and wireless providers, broadband operators, and contractors. This segment's products include wire and cables, transformers, transmission and distribution hardware, switches, protective devices, connectors, conduits, pole line hardware, racks, cabinets, safety and MRO products, and point-to-point wireless devices. This segment also offers various service solutions, including fiber project management, high and medium voltage project design and support, pre-wired meters and capacitor banks, meter testing and metering infrastructure installation, personal protective equipment dielectric testing, and tool repair, as well as emergency response, storage yard, materials, and logistics management. The company was founded in 1922 and is headquartered in Pittsburgh, Pennsylvania.
NYSE ended the session with WESCO falling 29.92% to $134.93 on Tuesday while NYSE fell 1.7% to $17,037.32.
Earnings Per Share
As for profitability, WESCO has a trailing twelve months EPS of $15.
PE Ratio
WESCO has a trailing twelve months price to earnings ratio of 9. Meaning, the purchaser of the share is investing $9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.57%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 13, 2023, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 0.86%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.6%, now sitting on 22.47B for the twelve trailing months.
More news about WESCO.
2. FibroGen (FGEN) – -16.91%
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
NASDAQ ended the session with FibroGen sliding 16.91% to $2.26 on Tuesday, following the last session’s downward trend. NASDAQ fell 1.8% to $15,655.60, following the last session’s downward trend on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, FibroGen has a trailing twelve months EPS of $-3.06.
Revenue Growth
Year-on-year quarterly revenue growth grew by 155.1%, now sitting on 154.98M for the twelve trailing months.
Moving Average
FibroGen’s worth is way above its 50-day moving average of $0.83 and way under its 200-day moving average of $4.87.
Volatility
FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was 12.67%, 5.00%, and 8.40%.
FibroGen’s highest amplitude of average volatility was 12.67% (last week), 10.99% (last month), and 8.40% (last quarter).
More news about FibroGen.
3. Shopify (SHOP) – -12.88%
Shopify Inc., a commerce company, provides a commerce platform and services in Canada, the United States, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company's platform enables merchants to displays, manages, markets, and sells its products through various sales channels, including web and mobile storefronts, physical retail locations, pop-up shops, social media storefronts, native mobile apps, buy buttons, and marketplaces; and enables to manage products and inventory, process orders and payments, fulfill and ship orders, new buyers and build customer relationships, source products, leverage analytics and reporting, manage cash, payments and transactions, and access financing. It also sells custom themes and apps, and registration of domain names; and merchant solutions, which include accepting payments, shipping and fulfillment, and securing working capital. The company was formerly known as Jaded Pixel Technologies Inc. and changed its name to Shopify Inc. in November 2011. Shopify Inc. was incorporated in 2004 and is headquartered in Ottawa, Canada.
NYSE ended the session with Shopify falling 12.88% to $77.64 on Tuesday, following the last session’s downward trend. NYSE slid 1.7% to $17,037.32, after five sequential sessions in a row of gains, on what was an all-around bearish trend exchanging session today.
Earnings Per Share
As for profitability, Shopify has a trailing twelve months EPS of $-0.9.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.53%.
Sales Growth
Shopify’s sales growth is 19.7% for the ongoing quarter and 26.5% for the next.
More news about Shopify.
4. Roku (ROKU) – -10.77%
Roku, Inc., together with its subsidiaries, operates a TV streaming platform. The company operates in two segments, Platform and Devices. Its streaming platform allows users to find and access TV shows, movies, news, sports, and others. The company also provides digital advertising and related services, including the demand-side ad platform and content distribution services, such as subscription and transaction revenue shares; media and entertainment promotional spending services; premium subscriptions services; video and display advertising services; and sells branded channel buttons on remote controls of streaming device. In addition, it offers billing services; and brand sponsorship and promotions, as well as manufactures, sells, and licenses smart TVs under the Roku TV name. Further, the company provides streaming players, audio products, and smart home products and accessories under the Roku brand name. It offers its products and services through retailers and distributors, as well as directly to customers through its website in the United States, Mexico, Canada, the United Kingdom, Brazil, and Germany. Roku, Inc. was incorporated in 2002 and is headquartered in San Jose, California.
NASDAQ ended the session with Roku falling 10.77% to $87.95 on Tuesday, after five consecutive sessions in a row of gains. NASDAQ dropped 1.8% to $15,655.60, following the last session’s downward trend on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, Roku has a trailing twelve months EPS of $-6.19.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.15%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Roku’s EBITDA is -30.27.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 67.6% and 47.8%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Roku’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for Roku is 6750740 which is 20.96% above its average volume of 5580690.
Previous days news about Roku
- Stay ahead of the game with Roku (Roku) Q4 earnings: wall street's insights on key metrics. According to Zacks on Monday, 12 February, "View all Key Company Metrics for Roku here>>>Shares of Roku have experienced a change of +11.3% in the past month compared to the +5.8% move of the Zacks S&P 500 composite. ", "Bearing this in mind, let’s now explore the average estimates of specific Roku metrics that are commonly monitored and projected by Wall Street analysts."
More news about Roku.
5. Full House Resorts (FLL) – -10.47%
Full House Resorts owns, leases, develops and operates gaming facilities throughout the country. The Company's properties include The Temporary by American Place in Waukegan, Illinois; Silver Slipper Casino and Hotel in Hancock County, Mississippi; Bronco Billy's Casino and Hotel in Cripple Creek, Colorado; Rising Star Casino Resort in Rising Sun, Indiana; Stockman's Casino in Fallon, Nevada; and Grand Lodge Casino, located within the Hyatt Regency Lake Tahoe Resort, Spa and Casino in Incline Village, Nevada. The Company is currently constructing Chamonix Casino Hotel, a new luxury hotel and casino expected to open in December 2023 in Cripple Creek, Colorado.
NASDAQ ended the session with Full House Resorts sliding 10.47% to $4.95 on Tuesday while NASDAQ slid 1.8% to $15,655.60.
Earnings Per Share
As for profitability, Full House Resorts has a trailing twelve months EPS of $-0.56.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19.8%.
Volatility
Full House Resorts’s last week, last month’s, and last quarter’s current intraday variation average was 3.78%, 0.45%, and 2.98%.
Full House Resorts’s highest amplitude of average volatility was 4.20% (last week), 2.59% (last month), and 2.98% (last quarter).
Moving Average
Full House Resorts’s value is below its 50-day moving average of $5.05 and under its 200-day moving average of $5.46.
Revenue Growth
Year-on-year quarterly revenue growth grew by 72.8%, now sitting on 217.11M for the twelve trailing months.
More news about Full House Resorts.
6. Aware, Inc. (AWRE) – -10.26%
Aware, Inc., a authentication company, provides biometrics software products and solutions for government agencies and commercial entities in the United States, Brazil, the United Kingdom, and internationally. The company offers biometric software solution, which includes Knomi, a mobile biometric framework which provides multiple biometric modality options; AwareABIS, an automated biometric identification system used for large-scale biometric identification and deduplication; AFIX suite used for small-scale law enforcement focused biometric identification; and AFIX Tracker for fingerprint, palmprint, and latent print identification. It also provides BioSP, a service-oriented platform enables biometric system with advanced biometric data processing and management in a web services architecture; WebEnroll, a browser-based biometric enrollment and data management solution; and AwareID, an adaptive authentication platform provides biometric face and voice analysis, and document validation for cloud-based biometric application programming interfaces and turnkey services. In addition, the company offers biometrics applications, such as Nexa line, a biometric search and match SDKs including Nexa Fingerprint, Nexa Face, Nexa Iris, and Nexa Voice; and AwareXM, an interoperable fingerprint matching SDK that provides fingerprint minutiae extraction, template generation, and fingerprint authentication. Further, it sells imaging products used in medical and advanced imaging application; offers program management and software engineering services, and software maintenance services. The company sells its products, services, and solutions through systems integrators, direct, and original equipment manufacturers and value added resellers channel Aware, Inc. was incorporated in 1986 and is headquartered in Burlington, Massachusetts.
NASDAQ ended the session with Aware, Inc. falling 10.26% to $1.75 on Tuesday while NASDAQ slid 1.8% to $15,655.60.
Earnings Per Share
As for profitability, Aware, Inc. has a trailing twelve months EPS of $-0.23.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12%.
More news about Aware, Inc..
7. Arcturus Therapeutics (ARCT) – -10.21%
Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California.
NASDAQ ended the session with Arcturus Therapeutics falling 10.21% to $37.37 on Tuesday while NASDAQ slid 1.8% to $15,655.60.
Earnings Per Share
As for profitability, Arcturus Therapeutics has a trailing twelve months EPS of $3.76.
PE Ratio
Arcturus Therapeutics has a trailing twelve months price to earnings ratio of 9.94. Meaning, the purchaser of the share is investing $9.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.66%.
Moving Average
Arcturus Therapeutics’s value is way above its 50-day moving average of $29.67 and way higher than its 200-day moving average of $27.94.
Sales Growth
Arcturus Therapeutics’s sales growth is negative 76.4% for the present quarter and negative 61.6% for the next.
Volume
Today’s last reported volume for Arcturus Therapeutics is 353171 which is 16.5% below its average volume of 422977.
More news about Arcturus Therapeutics.
8. Pacific Biosciences of California (PACB) – -9.84%
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
NASDAQ ended the session with Pacific Biosciences of California dropping 9.84% to $6.05 on Tuesday while NASDAQ slid 1.8% to $15,655.60.
Earnings Per Share
As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-1.27.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.46%.
Sales Growth
Pacific Biosciences of California’s sales growth is 108.4% for the ongoing quarter and 57.6% for the next.
Volume
Today’s last reported volume for Pacific Biosciences of California is 5644070 which is 18.89% below its average volume of 6959380.
More news about Pacific Biosciences of California.
9. Plug Power (PLUG) – -9.74%
Plug Power Inc. delivers end-to-end clean hydrogen and zero-emissions fuel cell solutions for supply chain and logistics applications, on-road electric vehicles, stationary power market, and others in North America and internationally. It engages in building an end-to-end green hydrogen ecosystem, including liquid green hydrogen production, storage and handling, transportation, and dispensing infrastructure. The company offers GenDrive, a hydrogen-fueled proton exchange membrane (PEM) fuel cell system that provides power to material handling electric vehicles; GenFuel, a liquid hydrogen fueling delivery, generation, storage, and dispensing system; GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive fuel cell systems, GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products, and ProGen fuel cell engines; and GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors. It also provides GenKey, an integrated turn-key solution for transitioning to fuel cell power; ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; Liquefaction systems; and Electrolyzers that are hydrogen generators optimized for clean hydrogen production. The company sells its products through a direct product sales force, original equipment manufacturers, and dealer networks. Plug Power Inc. was founded in 1997 and is headquartered in Latham, New York.
NASDAQ ended the session with Plug Power sliding 9.74% to $4.13 on Tuesday, after two consecutive sessions in a row of gains. NASDAQ slid 1.8% to $15,655.60, following the last session’s downward trend on what was an all-around down trend exchanging session today.
Earnings Per Share
As for profitability, Plug Power has a trailing twelve months EPS of $-1.6.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.57%.
More news about Plug Power.
10. Canopy Growth (CGC) – -9.48%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth sliding 9.48% to $3.44 on Tuesday while NASDAQ fell 1.8% to $15,655.60.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-15.83.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.66%.
Sales Growth
Canopy Growth’s sales growth for the next quarter is negative 15.4%.
Moving Average
Canopy Growth’s value is way below its 50-day moving average of $5.31 and way below its 200-day moving average of $6.74.
Yearly Top and Bottom Value
Canopy Growth’s stock is valued at $3.44 at 16:32 EST, below its 52-week low of $3.46.
More news about Canopy Growth.
Stay up to date with our winners and losers daily report
